C12N 2720/12264
By serial passage
Official title: by serial passage
C12N2720/12264 (By serial passage) appears on 5 US grants and 6 published applications in this corpus.
Search patents in C12N- Granted patents
- 5
- Published applications
- 6
- Assignees
- 6
- Inventors
- 7
- Latest grant
- 17 Aug 2021
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2009 | 0 | 1 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 2 |
| 2018 | 1 | 2 |
| 2019 | 1 | 0 |
| 2020 | 2 | 1 |
| 2021 | 1 | 0 |
By publication year.
Recent patents
- Avian reovirus vaccines17 Aug 2021US 11,090,377 B2University of Georgia Research Foundation, Inc.
- Attenuated reovirus2 Jun 2020US 10,668,119 B2Virocure, Inc.
- Avian reovirus vaccines17 Mar 2020US 10,588,958 B2University of Georgia Research Foundations, Inc.
- Attenuated reovirus16 Apr 2019US 10,260,049 B2Virocure, Inc.
- Avian reovirus vaccines15 May 2018US 9,968,671 B2University of Georgia Research Foundation, Inc.
- Avian reovirus vaccines5 Mar 2020US 2020/0069788 A1University of Georgia Research Foundation, Inc.
- Vaccines and diagnostics for novel porcine orthoreoviruses15 Nov 2018US 2018/0326034 A1Virginia Tech Intellectual Properties, Inc.
- Avian reovirus vaccines23 Aug 2018US 2018/0236061 A1University of Georgia Research Foundation, Inc.
- Attenuated reovirus23 Feb 2017US 2017/0049829 A1Virocure, Inc.
- Avian reovirus vaccines2 Feb 2017US 2017/0028055 A1University of Georgia Research Foundation, Inc.
Most cited
By later US patents